CrystalsFirst announces its generative AI extension - FragAI - as part of the MAGNET platform.

CrystalsFirst’s MAGNET platform overcomes current limitations of small molecule drug discovery. Our proprietary technology SmartSoak^® detects molecular magnets and generative AI identifies novel molecules and druggable binding pockets. 

Applications and features of FragAI: 

• Intellectual Property shield and protection
• Ligand- and structure-based workflows
• Fragment evolution for FBDD
• Hit-to-lead and lead optimization tailoring the target product profile
• Compatible with X-ray crystallography and CryoEM derived structures